Neurobehavioral Therapy for Conversion Disorder
(NBT for mFND Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests Neurobehavioral Therapy (NBT) to determine its effectiveness for individuals with motor functional neurological disorder (mFND), a condition affecting movement without an obvious physical cause. Researchers aim to discover if NBT can reduce symptoms and enhance daily functioning compared to standard medical care. Participants will either receive 12 weekly sessions of NBT alongside their usual care or continue with their usual care alone. Individuals diagnosed with mFND who have experienced symptoms in the past year may be suitable for this trial. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could improve future treatments for mFND.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. Participants will continue their standard medical care, so it's likely you can keep taking your current meds.
What prior data suggests that Neurobehavioral Therapy is safe for treating motor functional neurological disorder?
Research has shown that Neurobehavioral Therapy (NBT) is generally safe for treating functional neurological disorders. In previous studies, patients who received this therapy experienced better results without major safety issues. Although these studies focused on clinical outcomes, they did not report significant harmful side effects. This indicates that patients usually tolerate NBT well. However, consulting a healthcare professional is essential to understand what this means personally.12345
Why are researchers excited about this trial?
Researchers are excited about neurobehavioral therapy for conversion disorder because it offers a new approach that integrates psychological and physical treatment. Unlike standard medical care that primarily focuses on managing symptoms, this therapy empowers patients by using a structured workbook to help them regain control over their movements. The therapy is delivered through weekly virtual sessions complemented by in-person visits, providing a flexible and comprehensive support system. This innovative method aims not only to treat symptoms but also to address the underlying behavioral aspects of conversion disorder, potentially leading to more effective and lasting results.
What evidence suggests that Neurobehavioral Therapy might be an effective treatment for motor functional neurological disorder?
Neurobehavioral Therapy (NBT), which participants in this trial may receive, has shown promise in treating functional neurological disorders. For instance, one study found that therapy reduced seizures in most patients. Another study demonstrated that a structured therapy approach improved outcomes for patients with motor functional neurological disorder (mFND). Additionally, an outpatient therapy program reduced anxiety, depression, and daily challenges in patients with similar conditions. These findings suggest that NBT may alleviate symptoms of mFND and enhance overall well-being.12678
Who Is on the Research Team?
W. Curt LaFrance Jr, MD, MPH
Principal Investigator
Brown University Health
Emily Weisbach, MD
Principal Investigator
Brown University Health
Are You a Good Fit for This Trial?
This trial is for individuals aged 18 to 70 with Motor Functional Neurological Disorder (mFND), which includes symptoms like panic attacks and conversion disorder. Participants should be able to attend treatment sessions over several weeks and commit to five in-person clinic visits for assessments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Neurobehavioral Therapy or Standard Medical Care. Neurobehavioral Therapy involves weekly one-hour sessions over 12 to 18 weeks, while Standard Medical Care involves routine care with clinicians.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at Baseline, 6 weeks, 12 weeks, 8 months, and 12 months.
What Are the Treatments Tested in This Trial?
Interventions
- Neuro-behavioral Therapy
Trial Overview
The study compares Neurobehavioral Therapy (NBT) against Standard Medical Care (SMC) in patients with mFND. It aims to determine if NBT can improve quality of life and reduce symptom severity, measured by SF-36 and PMDRS/S-FMDRS scales, through regular sessions over 12-18 weeks.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will receive neuro-behavioral therapy (NBT), in individual, weekly, one-hour appointments, using the 12 session, "Taking Control of Your Functional Movements: Workbook", over the course of 12 to 18 weeks. Before each appointment, participants will complete worksheets/questions in one chapter that will be discussed during the weekly virtual appointment. Video appointments will be completed using an encrypted healthcare weblink and will be digitally recorded for review to ensure therapy adherence and competence. Participants randomized to the NBT arm will also participate in 5 in-person visits for exam documentation.
If randomized to this treatment arm, participants will continue to follow up with their clinicians while receiving standard medical care (SMC) and without receiving the study intervention. Research staff will ask about what care participants are receiving when they meet with staff. Subjects randomized to the SMC arm will participate in 5 in-person visits for exam and SMC documentation.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rhode Island Hospital
Lead Sponsor
Citations
Treatment outcomes in functional neurological disorder
Seven out of eight studies found seizure frequency reductions following psychotherapy in cohorts with average symptom durations of 3–10 years.
Pilot Neurobehavioral Therapy for Functional Neurological ...
The goal of this Clinical Trial is to investigate the feasibility and efficacy of Neuro-Behavioral Therapy in Individuals aged 18 to 70 diagnosed with Motor ...
Clinician-rated outcomes of patients with functional ...
This study reveals improved clinician-rated patient clinical outcomes in motor FND and in FND seizures using manualized therapy.
Routine outcomes and evaluation of an 8-week outpatient ...
This outpatient therapy program provided effective treatment for FND. Patients reported reduced anxiety, depression, and functional impairment.
Treatment for Patients With a Functional Neurological ...
Disability in functional neurological disorders is like that of structural disease, and neurological outcome at 8 months is poor, with over 50% ...
Current Concepts in Diagnosis and Treatment of Functional ...
Functional neurological disorders are common and disabling but potentially reversible. A positive or inclusionary diagnosis can be made with a high level of ...
Optimizing outcomes when treating functional neurological ...
Overall, patients with functional neurological disorder (FND) report decreased quality of life, similar to that of other neurological disorders.
Clinician-rated outcomes of patients with functional ...
We aimed to examine clinical outcomes in outpatients with FND treated with the Neuro-Behavioral Therapy (NBT) approach.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.